← Back to Search

REMM-HIIT for Post-COVID-19 Critical Illness (REMMHIIT-COVID Trial)

N/A

Waitlist Available

Led By Paul Wischmeyer, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-discharge, 6 months post-hospital discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial uses technology to remotely monitor and support high-intensity exercise for COVID-19 survivors. The goal is to help these patients rebuild their strength and fitness through short bursts of intense exercise.

Eligible Conditions

Coronavirus
Fitness Trackers
Difficult Weaning
Intensive Care Unit
High Intensity Interval Training
Critical Illness

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-discharge, 6 months post-hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-discharge, 6 months post-hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-discharge, 6 months post-hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Change in 6 minute walk test distance from baseline to 3 months after hospital discharge

Change in cognition from 3 months to 6 months after hospital discharge.

Change in cognition from baseline to 3 months after hospital discharge.

+5 more

Other study objectives

Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-discharge

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching.

Group II: ComparatorExperimental Treatment1 Intervention

Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)

2022

N/A

~20

Do I qualify?Apply below to find out